Effect of eradicating H. pylori on the appearance of esophageal reflux disease: Randomized double blind study;Vliv eradikace H. pylori na vznik refluxní choroby jícnu: Randomizovaná dvojitě slepá studie

Prakticky Lekar

Volumn 85, Issue 3, 2005, Pages 133-138

  Martínek, Jan ^a   Spicak J ^a   Benes M ^a   Zavoral, M ^b   Lukas M ^c   Mandys, V ^d   Kocna, P ^e   Kykal, J ^f  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b IPVZ   (Czech Republic)

^c CHARLES UNIVERSITY   (Czech Republic)

^d CHARLES UNIVERSITY   (Czech Republic)

^e CHARLES UNIVERSITY   (Czech Republic)

^f Nemocnice Ricany   (Czech Republic)

Author keywords

Eradication; Gastroesophageal; Helicohacter pylori; Reflux disease

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CLARITHROMYCIN; OMEPRAZOLE; PLACEBO;

ANTIGEN DETECTION; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFICACY; DYSPEPSIA; ERADICATION THERAPY; FECES ANALYSIS; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HELICOBACTER PYLORI; HUMAN; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REFLUX ESOPHAGITIS; RELIABILITY; RISK FACTOR; SCREENING TEST; SHORT COURSE THERAPY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY;

EID: 17444403203     PISSN: 00326739     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. El-Serag, H. B., Sonnenberg, A. Opposing time trends of peptic ulcer and reflux disease. Gut, 1998, 43, p. 327-333.
2. O'Connor, H. J. Helicobacter pylori and gastro-oesophageal reflux - clinical implications and management. Aliment, Pharmacol. Ther., 1999, 13, p. 117-127.
3. Vigneri, S., Termini, R., Savarino, V., Pace, F. Review article: is Helicobacter pylori status relevant in the management of GORD? Aliment. Pharmacol. Ther., 2000, 14, (Suppl. 3), p. 31-42.
4. Vicari, J. J., Peek, R. M., Falk, G. W., et al. The seroprevalence of cagA-positive Helicobacter pylori strains in the spectrum of gastroesophageal reflux disease. Gastroenterology, 1998, 115, p. 50-57.
5. Labenz, J., Blum, A., Bayerdorffer, L., et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology, 1997, 112, p. 1442-1447.
6. Koike, T., Ohara, S., Sekine, H., et al. Increase of acid gastric secretion after H. pylori eradication caused the development of reflux esophagitis (abstract). Gastroenterology, 1998, 114, p. A183.
7. Saccá, A., De Medici, A., Rodino, S., et al. Reflux esophagitis: a complication of Helicobacter pylori eradication therapy? Endoscopy, 1997, 29, p. 224.
8. O'Connor, H. J., Cunnanek, K. Helicobacter pylori and gastroesophageal reflux disease. A prospective study. Ir. J. Med. Sci., 1994, 113, p. 369-373.
9. Malfertheiner, P., Veldhuyzen van Zanten, S., Dent, J. et al. Does cure of Helicobacter pylori infection induce heartburn? Gastroenterology, 1998, 114, p. A212.
10. Tefera, S., Hatlebakk, J. G., Berstad, A. The effect of Helicobacter pylori eradication on gastro-esophageal reflux. Aliment. Pharmacol. Then, 1999, 13, p. 915-920.
11. Carbone, F., Neri, M., Laterza, F., et al. Twenty-four hour esophageal pHmetry in patients with non-ulcer dyspepsia is unchanged after H. pylori eradication (abstract), gastroenterology, 1998, 114, G0342.
12. Fixa, B., Komárková, O., Nožička, Z. Effect of eradikation of Hp infection on dyspeptic complaints in patients with peptic ulcer disease and with functional dyspepsia. Long-term follow-up study. Čes. Slov. Gastroent. Hepatol., 2004, 58, p. 3-7.
13. Blum, A. L., Talley, N. J., O'Morain, C. A., et al. Lack of effect of treating H. pylori infection in patients with non-ulcer dyspepsia. N. Engl. J. Med., 1998, 339, p. 1875-1881.
14. Fuchs, C. S., Mayer, R. J. Gastric Carinoma. N. Engl. J. Med., 1995, 333, p. 32-41.
15. Drossman, D. A., et al. Rome II: The Functional Gastrointestinal disorders. Degnon Associates 2000.
16. Kolektiv autorů. Refluxní choroba jícnu - standardy Českě gastroenterologické společnosti. Praha, 2000.
17. Martínek, J., Špičák, J., Pantoflíčková, D. Helicobacter pylori a peptický vřed: Co nověho. Čes. Slov. Gastroenterol., 2000, 54, p. 24-34.
18. Chow, W. F. L., Blaser, M. J., Blot, W. J., et al. An inverse correlation between CagA+ strains of Helicobacter pylori infection and risk of oesophageal and gastric cardia adenocarcinoma. Cancer Res., 1998, 58, p. 588-590.
19. Hansen, S., Melby, K. K., Aase, S., et al. Helicobacter pylori infection and risk of cardia cancer and non-cardia gastric cancer. Scand. J. Gastroenterol., 1999, 34, p. 353-360.
20. Malfertheiner, P., Megraud, F., O'Morain, C., et al. European Helicobacter Pylori Study Group (EHPSG). Current concepts in the management of Helicobacter pylori infection - the Maastricht 2 - 2000 Consensus Report. Aliment. Pharmacol. Ther., 2002, 16, p. 167-180.